- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
Patent holdings for IPC class A61K 31/525
Total number of patents in this class: 753
10-year publication summary
|
60
|
64
|
74
|
52
|
110
|
98
|
88
|
56
|
50
|
65
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| DSM IP Assets B.V. | 5395 |
57 |
| Société des Produits Nestlé S.A. | 10060 |
45 |
| CXL Ophthalmics, LLC | 19 |
12 |
| Avedro, Inc. | 138 |
10 |
| Zensun (Shanghai) Science & Technology, Co., Ltd. | 55 |
10 |
| Nulixir Inc. | 42 |
10 |
| Nicoventures Trading Limited | 4876 |
9 |
| Sooft Italia SpA | 16 |
8 |
| The Board of Trustees of the Leland Stanford Junior University | 6724 |
7 |
| Matthias W. Rath | 24 |
7 |
| N.V. Nutricia | 1102 |
7 |
| Nestec S.A. | 2536 |
6 |
| Nutri Co., Ltd. | 45 |
6 |
| Reven Pharmaceuticals, Inc. | 8 |
6 |
| TIMA Foundation | 10 |
6 |
| Trioptotec GmbH | 16 |
6 |
| Ajinomoto Co., Inc. | 2291 |
5 |
| Academisch Ziekenhuis Groningen | 123 |
5 |
| Aprofol AG | 23 |
5 |
| Kaeco Group, Inc. | 10 |
5 |
| Other owners | 521 |